Brokerages expect Varian Medical Systems, Inc. (NYSE:VAR) to report $0.99 earnings per share (EPS) for the current quarter, according to Zacks. Four analysts have provided estimates for Varian Medical Systems’ earnings. The lowest EPS estimate is $0.92 and the highest is $1.02. Varian Medical Systems posted earnings of $0.75 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 32%. The business is expected to issue its next earnings report after the market closes on Wednesday, January 24th.

According to Zacks, analysts expect that Varian Medical Systems will report full-year earnings of $4.25 per share for the current fiscal year, with EPS estimates ranging from $4.25 to $4.26. For the next fiscal year, analysts expect that the firm will post earnings of $4.60 per share, with EPS estimates ranging from $4.55 to $4.65. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that follow Varian Medical Systems.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.10). The business had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company’s revenue was down 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.03 EPS.

A number of analysts recently issued reports on the company. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the company a “hold” rating in a research report on Thursday, November 30th. Citigroup upped their target price on Varian Medical Systems from $119.00 to $121.00 and gave the company a “neutral” rating in a research report on Monday, October 30th. Zacks Investment Research cut Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Finally, Robert W. Baird reaffirmed a “hold” rating and set a $99.00 price objective on shares of Varian Medical Systems in a research report on Monday, August 28th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of $98.39.

In other news, insider Dow R. Wilson sold 15,059 shares of the firm’s stock in a transaction that occurred on Friday, October 6th. The stock was sold at an average price of $102.40, for a total value of $1,542,041.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director R Andrew Eckert sold 5,651 shares of the firm’s stock in a transaction that occurred on Friday, October 6th. The shares were sold at an average price of $102.39, for a total value of $578,605.89. The disclosure for this sale can be found here. Insiders sold a total of 26,768 shares of company stock valued at $2,771,819 over the last three months. Insiders own 0.91% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Sei Investments Co. increased its stake in Varian Medical Systems by 2.3% in the 2nd quarter. Sei Investments Co. now owns 11,593 shares of the medical equipment provider’s stock valued at $1,196,000 after purchasing an additional 257 shares in the last quarter. Schwab Charles Investment Management Inc. increased its stake in Varian Medical Systems by 2.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 432,659 shares of the medical equipment provider’s stock valued at $44,647,000 after purchasing an additional 9,702 shares in the last quarter. Conning Inc. increased its stake in Varian Medical Systems by 1.3% in the 2nd quarter. Conning Inc. now owns 2,381 shares of the medical equipment provider’s stock valued at $246,000 after purchasing an additional 30 shares in the last quarter. Dupont Capital Management Corp increased its stake in Varian Medical Systems by 19.6% in the 2nd quarter. Dupont Capital Management Corp now owns 6,465 shares of the medical equipment provider’s stock valued at $667,000 after purchasing an additional 1,061 shares in the last quarter. Finally, BNP Paribas Arbitrage SA increased its stake in Varian Medical Systems by 32.5% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 102,502 shares of the medical equipment provider’s stock valued at $10,577,000 after purchasing an additional 25,152 shares in the last quarter. 99.15% of the stock is owned by institutional investors and hedge funds.

Shares of Varian Medical Systems (NYSE VAR) traded up $2.10 during midday trading on Friday, hitting $111.87. The company had a trading volume of 883,273 shares, compared to its average volume of 645,538. The firm has a market cap of $10,249.19, a PE ratio of 29.67, a PEG ratio of 3.29 and a beta of 0.67. Varian Medical Systems has a 1 year low of $75.54 and a 1 year high of $114.09.

TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Expect Varian Medical Systems, Inc. (VAR) Will Announce Earnings of $0.99 Per Share” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/12/17/zacks-brokerages-expect-varian-medical-systems-inc-var-will-announce-earnings-of-0-99-per-share.html.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Get a free copy of the Zacks research report on Varian Medical Systems (VAR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.